作者
Rongbao Zhao, Andong Qiu, Eugenia Tsai, Michaela Jansen, Myles H Akabas, I David Goldman
发表日期
2008/9/1
期刊
Molecular pharmacology
卷号
74
期号
3
页码范围
854-862
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
The reduced folate carrier (RFC) and the proton-coupled folate transporter (PCFT) are ubiquitously expressed in normal and malignant mammalian tissues and in human solid tumor cell lines. This article addresses the extent to which PCFT contributes to transport of pemetrexed and to the activities of this and other antifolates relative to RFC at physiological pH. Either RFC or PCFT cDNA was stably transfected into a transporter-null HeLa cell variant to achieve activities similar to their endogenous function in wild-type HeLa cells. PCFT and RFC produced comparable increases in pemetrexed activity in growth medium with 5-formyltetrahydrofolate. However, PCFT had little or no effect on the activities of methotrexate, N-(5-[N-(3,4-dihydro-2-methyl-4-oxyquinazolin-6-ylmethyl)-N-methyl-amino]-2-thenoyl)-l-glutamic acid (raltitrexed, Tomudex; ZD1694), or Nα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l-ornithine …
引用总数
20082009201020112012201320142015201620172018201920202021202220232024113161418121210159109611252